News
- Details
On November 15, 2018, within the framework of a regular meeting of the Sverdlovsk Association of Endocrinologists, the results of clinical trials of Rosinsulin M Mix 30/70, 2-phase genetically engineered human insulin, were presented in Rymar Oksana's report “Basic clinical and laboratory parameters in patients with type 2 diabetes mellitus amid the therapy of combined domestic insulins and metformins in the real-world clinical practice."
- Details
- Details
On July 19, the Medsintez plant arranged the first open excursion for schoolchildren as part of an educational Science program. It involved talented students from 30 municipalities of the Sverdlovsk Region. They have already learned most of the lecture material from such areas as the medicine of the future, chemistry and pharmacy. This July educational program was organized by the Golden Section Fund, which supports talented children and youth. The excursion to the plant promoted knowledge consolidation.
- Details
On July 9-12, 2018, the INNOPROM International Industrial Exhibition was held in Yekaterinburg, where a stand of the Ural Biomedical Cluster was presented too. The exhibition's format provided for active communication between business and representatives of the Government of the Russian Federation, the Sverdlovsk region and foreign countries. It helped the exhibition participants to get familiar with innovative technologies, establish trade and economic bonds, promote products of Russian enterprises to new markets and implement promising investment projects.
- Details
© 2003 - 2019 LLC "Plant Medsintez"
Torgovaya 15, Novouralsk, Sverdlovsk region, Russia, 624130